Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

About Diabetes

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

A1c Outperforms Fasting Glucose for Diabetes Risk Prediction
Posted: Sunday, March 21, 2010
Measurements of hemoglobin A1c (HbA1c) more accurately identify persons at risk for clinical outcomes than the commonly used measurement of fasting glucose, according to a new published study.

The White House Blog: Voices of Reform
Posted: Wednesday, March 17, 2010
There’s no issue that touches people more directly than health care, so there’s good reason for people to want as much reassurance as they can get before the country goes ahead with reform. That’s why those who work in our health care system day in and day out have a unique role in weighing in on the merits of any reform effort.

In an unprecedented show of diverse, even sweeping support, a virtual army of organizations came out in support of the President’s health reform proposal this morning as Congress prepares to make its final decisions.

Special Newsflash: Exenatide Once Weekly -- FDA Update
Posted: Tuesday, March 16, 2010
Amylin, Lilly and Alkermes received a Complete Response Letter from FDA for Exenatide Once Weekly. New drug to be called BYDUREON (exenatide for extended-release injectable suspension).

In the complete response letter there are no requests for new pre-clinical or clinical trials. Requests raised in the letter primarily relate to the finalization of the product labeling with accompanying Risk Evaluation and Mitigation Strategy (REMS) and clarification of existing manufacturing processes.

A1c's Over Five Percent Increase Risk for Stroke
Posted: Sunday, March 14, 2010
Glycated hemoglobin (HbA1c), even at levels considered in the "normal" range, emerged as an independently significant predictor of heart-disease events, stroke, and death over more than a decade in an analysis from the Atherosclerosis Risk in Communities (ARIC) study. The risks of incident diabetes, coronary heart disease events, and death were significantly increased for all HbA1c values higher than the reference range of 5.0% to <5.5%.

Stinky Diabetes Drug May Result in Poor Adherence
Posted: Sunday, March 14, 2010
An immediate-release form of the antidiabetic agent metformin has a dead fish odor that may cause patients to stop taking the drug, clinicians warned.

Unhealthy Foods Become Less Popular with Increasing Costs -- JAMA
Posted: Sunday, March 14, 2010
Adults tend to eat less pizza and drink less soda as the price of these items increases, and their body weight and overall calorie intake also appear to decrease, according to a new report.

Ninety-two Percent of Pre-Diabetes Patients Are Unaware of their Status
Posted: Sunday, March 14, 2010
Most people are not aware whether they are pre-diabetic and most who know they are, are not doing anything about it, say U.S. health officials. And from the ARIC study, those with prediabetes are found to be at risk for cardiovascular disease with an A1c above 5%.

Dolphins Can Switch Off Insulin Resistance and Diabetes
Posted: Sunday, March 07, 2010
A study in dolphins has revealed genetic clues that could help medical researchers to treat Type 2 diabetes.

Increasing Vitamin D Can Reduce Type 2 Diabetes by 55 Percent
Posted: Sunday, March 07, 2010
People who get plenty of vitamin D can cut their chance of developing Type 2 diabetes by 55 percent, according to the review of over 100,000 people in 28 studies.

TZD Patients Are 50% More Likely to Develop Bone Fractures
Posted: Sunday, March 07, 2010
A Henry Ford Hospital study finds women with Type 2 diabetes who take a commonly prescribed class of medications called TZD's to treat insulin resistance may be at a higher risk for developing bone fractures within 1 year of taking the medication.

Page 67 of 288
 |<   <<   <  62  |  63  |  64  |  65  |  66  |  67  |  68  |  69  |  70  |  71  |  72  >   >>   >| 

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement